Diagnosis of systemic lupus erythematosus meeting the 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) SLE classification criteria at least 6 months prior to ...

Evaluation of cardiovascular risk in patients with prostate cancer initiating novel hormonal therapy. This is an ASCO Meeting Abstract from the 2024 ASCO Quality Care Symposium. This abstract does not ...

The researchers noted that BTK and BCL2 inhibitors, alone or as part of combination regimens, have proven superior to chemoimmunotherapy in the first-line and relapsed/refractory settings ...

When I first did a fellowship here at Ohio State, we had studies of ibrutinib, the first-in-class covalent Bruton tyrosine kinase (BTK) inhibitor. We'd see patients who'd been on chemotherapy for ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune checkpoint inhibitor therapy, according to a preclinical study.

In addition to REGENCY, Gazyva is being investigated in children and adolescents with lupus nephritis, people with membranous nephropathy, childhood-onset idiopathic nephrotic syndrome and systemic ...

(NASDAQ: AUPH) (Aurinia or the Company) today announced that the Japanese Ministry of Health, Labour, and Welfare has approved voclosporin, a second-generation calcineurin inhibitor, in ...